Tunnell Consulting experts bring thought leadership on driving innovation to advancing patient therapies at key industry event.

We hope to see you at the ISPE conference

Oct. 29 – Nov. 1!

In this week’s Outsourced Pharma, chief editor Louis Garguilo announced that Tunnell’s Julia O’Neill is among a small and exclusive group to join the publication’s Editorial Advisory Board. The editor notes that this group is expected to lead efforts in new challenges and emerging opportunities, and will add to the publication’s already strong leadership. Julia joins Anand Ekambaram, Executive Director Global Technical Operations from Merck, and Mark Butchko, Senior Director of Quality Assurance at Eli Lilly. Julia, along with the other two new board members, have all contributed to OursourcedPharma.com, and have been active at conferences, and the editor notes that Julia has been a key moderator at all three conference venues (San Diego, San Francisco, and Boston), and has been key to Outsourced Pharma’s continuing quest for authentic discussion between drug owners and external service providers.

Please join us in congratulating Julia on this important appointment!

Industry visionary Kip Wolf provides clarity, insights and innovative solutions to the changes and challenges of the pharma industry.

Abraham’s extensive insight and experience guides life sciences companies successfully through the regulatory process.

“Pharmaceutical companies must modernize their validation and risk management approaches.”

“Turesol is designed and prepared to respond to those temporary resource needs with speed and competitive pricing.”

“The only constant is change.”